Best Warren Buffett Companies To Own In Right Now

Best Warren Buffett Companies To Own In Right Now: BP p.l.c.(BP)

BP p.l.c. provides fuel for transportation, energy for heat and light, retail services, and petrochemicals products. Its Exploration and Production segment engages in the oil and natural gas exploration, field development, and production; midstream transportation, and storage and processing; and marketing and trading of natural gas, including liquefied natural gas (LNG), and power and natural gas liquids (NGL). This segment has exploration and production activities in Angola, Azerbaijan, Canada, Egypt, Norway, Russia, Trinidad and Tobago, the United Kingdom, and the United States, as well as in Asia, Australasia, South America, North Africa, and the Middle East. This segment also owns and manages crude oil and natural gas pipelines; processing facilities and export terminals; and LNG processing and transportation, as well as NGL extraction facilities. BP p.l.c. has interests in the Trans-Alaska pipeline system, the Forties pipeline system, the Central Area transmission sys tem pipeline, the South Caucasus Pipeline, and Baku-Tbilisi-Ceyhan pipeline, as well as in LNG plants located in Trinidad, Indonesia, and Australia. The company?s Refining and Marketing segment involves in the supply and trading, refining, manufacturing, marketing, and transportation of crude oil, petroleum, and petrochemicals products and related services to wholesale and retail customers primarily under the BP, Castrol, ARCO, and Aral brands. Its Other Businesses and Corporate segment produces and markets rolled aluminum products, as well as generates energy through wind, solar, biofuels, hydrogen, and carbon capture and storage sources; and engages in shipping activities. The company was founded in 1889 and is headquartered in London, the United Kingdom.

Advisors' Opinion:

• [By Aaron Levitt]

  Were in the thick of earnings season for the energy sector and BP (BP) and Occidental Petroleum (OXY) were the latest oil stocks to! report earnings.

source from Top Stocks To Buy For 2015:http://www.topstocksforum.com/best-warren-buffett-companies-to-own-in-right-now-3.html

Top 10 Building Product Stocks For 2016

Top 10 Building Product Stocks For 2016: Lloyds Banking Group PLC (LYG)

Lloyds Banking Group plc, incorporated on October 21, 1985, is a holding company. The Company is a financial services group providing a range of banking and financial services, primarily in the United Kingdom, to personal and corporate customers. The Company operates in four segments: Retail, Commercial Banking, Wealth, Asset Finance and International and Insurance. Retail provides banking, mortgages and other financial services to personal customers in the United Kingdom. Commercial Banking provides banking and related services to business clients, from small businesses to large corporate. Wealth, Asset Finance and International provides private banking and asset management and asset finance in the United Kingdom and overseas and operates the Companys international retail businesses. Insurance provides long term savings, protection and investment products in the United Kingdom and Europe and provides general insurance to personal customers in the United Kingdom.

Retail

The Retail division operates the retail bank in the United Kingdom and is a provider of current accounts, savings, personal loans, credit cards and mortgages. This includes a range of current accounts including packaged accounts and basic banking accounts. It is also the provider of personal loans in the United Kingdom, as well as being the United Kingdoms credit card issuer. Retail is the private sector savings provider in the United Kingdom. It is also a general insurance and bancassurance distributor, offering a range of long-term savings, investment and general insurance products.

Commercial Banking

The Commercial Banking division supports the Companys business clients from small businesses to corporate. Commercial Banking provides support to corporate clients through the provision of core banking products, such as lending, deposits and transaction banking services whilst also offering clients expe! rtise in capita l markets (private placements, bonds and syndicated loans), ! financial markets (foreign exchange, interest rate management, money market and credit) and private equity.

Wealth, Asset Finance and International

Wealth, Asset Finance and International consists of the Companys the United Kingdom and international wealth businesses, the Companys the United Kingdom and international asset finance and online deposit businesses along with its international retail businesses. The Wealth business consists of private banking and asset management. Wealths private banking operations cater to the range of wealth clients from affluent to Ultra High Net Worth within the United Kingdom, Channel Islands and Isle of Man, and internationally. Asset Finance consists of a number of leasing and speciality lending businesses in the United Kingdom, including Lex Autolease and Black Horse Motor and Personal Finance along with its leasing and specialty lending businesses in Australia and its European online deposit business. T he international business comprises its non-core banking business outside the United Kingdom, with the exception of corporate business written through the Commercial Banking division. This primarily consists of Ireland, Retail Europe and Asia.

Insurance

The Insurance division provides long-term savings, protection and investment products and general insurance products to customers in the United Kingdom and Europe. The United Kingdom Life, Pensions and Investments business provides long-term savings, protection and investment products distributed through the bancassurance, intermediary and direct channels of the Lloyds TSB, Halifax, Bank of Scotland and Scottish Widows brands. The European Life, Pensions and Investments business distributes products primarily in the German market under the Heidelberger Leben and Clerical Medical brands. The General Insurance business is a distributor of home insurance in the United Kingdom, with products! sold thr! ough the branch network, direct channels and strategic corporate! partners! . It operates primarily under the Lloyds TSB, Halifax and Bank of Scotland brands.

Advisors' Opinion:

• [By Stuart Watson]

  LONDON --A short statement fromLloyds Banking Group (LSE: LLOY  ) (NYSE: LYG  ) about its capital position helped its shares to rise on Wednesday morning, taking its one-month gain to nearly 35%.

source from Top Penny Stocks For 2015:http://www.seekpennystocks.com/top-10-building-product-stocks-for-2016-2.html

Mid-Cap Stocks Win Favor at ABN on Outlook for Growth

ABN Amro Private Banking is betting that smaller companies will benefit the most as corporations boost spending in 2014 amid the fastest global economic growth in four years.

Smaller firms will rally the most among equities worldwide as they provide the tools and goods needed for larger companies to grow, according to ABN Amro's wealth-management unit. Improving economic indicators mean the biggest companies will be more willing to increase expenditure and may look to acquire smaller competitors to support expansion, said Didier Duret, chief investment officer for the private bank.

"These companies are at the crossroads of innovation and new demand, and tend to benefit in the middle of an economic recovery," Amsterdam-based Duret, who helps oversee 164.5 billion euros ($220 billion), said in a phone interview yesterday. "Increased confidence and domestic drivers are why we've selected small- and medium-cap stocks in what is now a more mature market. The last time we did that was in 2005."

Earnings at companies in the MSCI World Mid-Cap Index will surge 93 percent in the three years through 2015, while profit for the benchmark MSCI World Index will advance 47 percent, according to analysts' estimates compiled by Bloomberg. The measure of mid-size stocks has rallied 19 percent this year through yesterday, while the gauge of the largest developed-market shares rose 16 percent.

In the U.S., the Standard & Poor's Mid-Cap 400 Index has climbed 21 percent in 2013, while the S&P 500 gauge of the largest companies has gained 19 percent.

Expedia, Arcadis

Companies like Expedia Inc. (EXPE), which provides online travel booking services, and Arcadis NV (ARCAD), a Dutch designer of bridges and dikes, are likely to increase profit at a faster pace than larger firms during an improving economy, Duret said. Smaller companies are also less leveraged, with U.S. mid-caps holding 46 percent less debt per share than firms listed on the S&P 500, data compiled by Bloomberg show.

Duret increased his equity allocation to 44 percent of assets in September from 40 percent in June. ABN Amro predicts the global economy will expand 3.8 percent in 2014. That would be the fastest pace since 2010 and more than the 2.9 percent growth projected by economists in a Bloomberg survey. The bank cut its cash holdings to 9 percent from 13 percent, according to a report published today.

ABN Amro's wealth-management unit maintained its overweight position in stocks for a fifth consecutive quarter, meaning it holds more of the assets than represented in benchmark portfolios.

"It looks like we are getting out of the woods, and it's widely spread and evenly distributed across the developed regions," said Duret. "There's a constructive scenario ahead of us where many forecasters may be surprised by the cumulative effect within the economy. It has been the longest recession I've seen in my career, and it's due time we got out it."

Best Transportation Companies For 2016

Best Transportation Companies For 2016: Western Refining Logistics LP (WNRL)

Western Refining Logistics, LP, incorporated on July 17, 2013, owns, operates, develops, and acquires terminals, storage tanks, pipelines, and other logistics assets. As of December 31, 2012, the Companys assets includes pipeline and gathering assets and terminalling, transportation, and storage assets in the Southwestern portion of the United States, which included approximately 300 miles of pipelines and approximately 7.9 million barrels of active storage capacity, as well as other assets. The Company's assets are integral to the operations of Westerns refineries located in El Paso, Texas, and near Gallup, New Mexico.

As of December 31, 2012, the Company owns and operates two refineries, in El Paso, Texas and Gallup, New Mexico, with a total crude oil throughput capacity of 153,000 barrels per day (bpd). The Company does not take ownership of the hydrocarbons or products (other than certain additives) that it handles or engages in the trading of any co mmodities.

Advisors' Opinion:

• [By Robert Rapier]

  Western Refining Logistics (NYSE: WNRL) debuted on Oct. 10. The partnership was formed by Western Refining (NYSE: WNR) to own, operate, develop and acquire terminals, storage tanks, pipelines, and other logistics assets. WNRL’s assets include 300 miles of crude oil pipelines, gathering systems, and 566,000 barrels of crude oil storage located primarily in the Permian Basin. Most of its revenue is expected to be derived from two 10-year, fee-based agreements with Western Refining.

• [By Aimee Duffy]

  It;s been a very robust year for master limited partnership IPOs to say the least. On Thursday, Western Refining (NYSE: WNR  ) successfully spun off its midstream logistics MLP, Western Refining Logistics (NYSE: WNRL  ) . The partnership became the 14th MLP to make its debut this year.

source from Top Stocks To Buy For 2015:http://www.topstocksforum.com/best-transportation-companies-for-2016-2.html

Top 10 Insurance Stocks To Own Right Now

Top 10 Insurance Stocks To Own Right Now: Genworth Financial Inc (GNW)

Genworth Financial, Inc., a financial security company, provides insurance, wealth management, investment, and financial solutions in the United States and internationally. The company offers various insurance and fixed annuity products, including life and long-term care insurance products; payment protection insurance products for consumers primarily to meet specified payment obligations; and wealth management products, such as managed account programs with advisor support and financial planning services. It also provides mortgage insurance products and related services to insure prime-based, individually underwritten residential mortgage loans or flow mortgage insurance; and mortgage insurance on a structured or bulk basis, as well as offers services, analytical tools, and technology that enable lenders to operate and manage risk. In addition, the company provides institutional products consisting of funding agreements, funding agreements backing notes, and guaranteed in vestment contracts. Genworth Financial, Inc. distributes its products and services through financial intermediaries, advisors, independent distributors, affinity groups, and sales specialists. The company was founded in 2003 and is headquartered in Richmond, Virginia.

Advisors' Opinion:

• [By Garrett Cook]

  Shares of Genworth Financial (NYSE: GNW) were down 35.89 percent to $9.02 following Wednesday's earnings miss.

  Web.com Group (NASDAQ: WWWW) shares tumbled 21.63 percent to $15.87 after the company reported Q3 earnings of $0.63 per share on revenue of $143.80 million and announced a $100 million stock repurchase authorization. JP Morgan downgraded Web.com Group from Overweight to Neutral and lowered the price target from $35.00 to $20.00.

• [By Ben Levisohn]

  When a stock loses a third of its v! alue in one day, it’s fair to say that something has gone very wrong. In the case of Genworth Financial (GNW), you might want to add a few very’s.

• [By Ben Levisohn]

  Genworth Financial (GNW) has plunged 23% to $10.86 after the insurance company suffered a massive loss due to the rising costs of its long-term care insurance business.

source from Top Stocks For 2015:http://www.topstocksblog.com/top-10-insurance-stocks-to-own-right-now-2.html

Top 5 Gas Utility Stocks To Watch Right Now

Top 5 Gas Utility Stocks To Watch Right Now: MedCAREERS Group Inc (MCGI)

MedCareers Group, Inc., incorporated on December 30, 2004, focus is to develop and build value through its wholly owned subsidiary Nurses Lounge (www.nurseslounge.com), an online professional network and communication source for nurses and organizations connected to the nursing community. On August 10, 2010, MedCareers acquired the workabroad.com Website from Steve Elisberg (Workabroad.com Website).

The Nurses Lounge is a professional network for nursing professionals providing relevant content and information and professional networking. Nurses can subscribe to Lounges created by nursing schools, nurse associations, employers, specialties and more to receive email updates of relevant news, events and other info. Professional networking is a place for nurses to connect with colleagues and network on a professional level.

Advisors' Opinion:

• [By Peter Graham]

  Last Friday, small cap stocks MedCAREERS Group Inc (OTCMKTS: MCGI), USmart Mobile Device Inc (OTCMKTS: UMDI) and Drinks Americas Holdings, Ltd (OTCMKTS: DKAM) were all over the place with the first two sinking 54% and 48.05%, respectively, while the last one rose 10.81%. It should be mentioned that all three small cap stocks have been the subject of paid promotions albeit none of these stocks have been over promoted. So where can investors and traders expect these stocks to head this week? Here is a quick look at what you might expect:

  MedCAREERS Group Inc (OTCMKTS: MCGI) Gets Additional Commitments to Join Its Subsidiary

  Small cap MedCAREERS Group aims to develop and build value through its wholly-owned subsidiary Nurses Lounge, Inc., an online professional network and communication source for nurses that offers a 21st century solution to recruitment and information that cannot be accomplished on a static nursing school or association website. On Friday, MedCAREERS Group sank 54% to $0.0575 for a ! market cap of $3.03 million plus MCGI is up 161.4% since the start of the year and down 93.9% over the past five years according to Google Finance.

source from Top Penny Stocks For 2015:http://www.seekpennystocks.com/top-5-gas-utility-stocks-to-watch-right-now.html

Best Communications Equipment Stocks To Watch Right Now

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What:�Shares of Calix (NYSE: CALX  ) dropped more than 30% during intraday trading Wednesday after the communications equipment supplier reported mixed third-quarter results and weak forward guidance.

So what:�Quarterly revenue increased 27%, to a record $103.6 million, which translated to adjusted net income of $10.2 million, or $0.20 per share. Analysts, on average, were expecting lower adjusted earnings of $0.14 per share on higher sales of $104.35 million.

What's more, Calix stated that while spending from its tier 2 and tier 3 customers has been strong so far this year, those customers have indicated spending will slow down in the fourth quarter. As a result, management expects Q4 revenue to fall sequentially to a range of $97 million to $103 million, which will result in adjusted earnings per share in the range of $0.03 to $0.08.

10 Best Financial Stocks For 2016: Location Based Technologies Inc (LBAS)

Location Based Technologies, Inc. (LBT), incorporated on April 20, 2006, designs, develops, and sells personal, pet, and vehicle locator devices and services including PocketFinder People, PocketFinder Pets and PocketFinder Vehicles. The Company markets and sells consumer and commercial location devices and services. Its devices utilize Assisted Global Positioning System (A-GPS) and General Packet Radio Service (GPRS) technologies in conjunction with its technologies designed to enhance the families to interact and stay connected around the world. The Company is a developer of the PocketFinder family of products and the PocketFinder Network. The PocketFinder family of products includes the PocketFinder People, PocketFinder Vehicle, PocketFinder Pets, PocketFinder Luggage, PocketFinder Mobile and PocketFinder Fleet. The PocketFinder is a small location device that enables a user to locate a device, person, or pet, at anytime from almost anywhere. PocketFinder personal locator devices are wireless.

The Company generate revenue by selling its products and charging customers an ongoing service fee, for which it offers monthly and annual subscription plans. The Company�� product, PocketFinder, is a small, waterproof and wireless location device that enables users to locate anyone or anything they care about, from a computer or Web-enabled device. Its products deliver critical information to users, such as: device location, longitude, latitude, heading speed and 60 days of location history. This information can be viewed passively through a user�� account or can be sent to a user via email or push notification if the user sets an alert. The target markets for the PocketFinder include: young children, seniors, people with special needs and people who need to track valuable assets such as luggage or sporting equipment. In addition to the PocketFinder, it also sell the PocketFinder Pet and the PocketFinder Vehicle products. The PocketFinder Pet is designed for pets weighing 15 pounds or more,! and it markets the PocketFinder Vehicle to families with new drivers, car enthusiasts, motorcycle owners, watercraft owners and business fleets. The PocketFinder Vehicle attaches directly to a battery or fuse box, so it has a constant supply of power. All PocketFinder products operate on the same user interface, which enables its customers receive the same features, functionality and user-experience, regardless of which product they own. To access their account or locate their devices, users can logon to the Company�� Website at www.pocketfinder.com or use its native iPhone, iPad or Android Apps.

The Company�� products are sold through various brick-and-mortar and online retailers and through its Website. It provides customer service and support in the United States through existing call centers owned by Affinitas. It provides wireless location based solutions for global positioning products along with its friendly user interface software system. PocketFinder and PocketFinder Vehicle devices are being sold in the United States and in Canada through the Apple Online Store and Apple Retail Stores. PocketFinder devices for Pets are available for purchase on its Website.

The Company competes with Geospatial Platform Providers, Application Developers, Garmin�� GTU-10, Qualcomm�� Tagg, Lo-Jack, SpotLight, Fleetmatics, NetworkFleet, and Qualcomm.

Advisors' Opinion:

• [By CRWE]

  Today, LBAS has shed (-7.69%) -0.010 at $.120 with 95,100 shares in play thus far (ref. google finance Delayed: 12:21PM EDT August 15, 2013).

  Location Based Technologies, Inc. previously reported it has signed a distribution agreement with Beijing Lava Technology Co. Ltd., an Apple approved distributor for its online, brick and mortar stores, and authorized distributors in Asia. The agreement is one of the final steps preceding the launch of LBT�� GPS products into the Asian markets. Beijing Lava Technology Co. Ltd. serves China, Singapore, Japan, Korea, Taiwan, Malaysia, and Indonesia.

  LBT estimates that it will begin selling its PocketFinder devices in Singapore through Apple�� online store and authorized distributors in the near future with other Asian countries to follow thereafter.

• [By CRWE]

  Today, LBAS�remains (0.00%) +0.000 at $.132 with 9,470 shares in movement thus far (ref. google finance Delayed: 9:47AM EDT June 20, 2013).

  Location Based Technologies, Inc. previously received FCC and IC certification for its versatile LBT-886 device. These certifications are necessary before devices can be sold to consumers throughout the US and Canada.

  The LBT-886 device is available for manufacture in a 2G or 3G variant. The 3G penta-band variant will enable the device to function in countries which only operate on the 3G spectrum, such as Australia, South Korea, Japan and some areas of Canada. This global tracking solution also delivers additional features such as various environmental sensors or comes with an attachment with special capability designed to meet lone-worker or personnel security requirements

• [By CRWE]

  Today, LBAS surged (+10.27%) up +0.015 at $.160 with�39,780 shares in play thus far (ref. google finance Delayed: 11:41AM EDT July 5, 2013).

  Location Based Technologies, Inc. and EE, Ltd., the U.K.�� most advanced communications company, have previously entered into a purchase agreement which will allow LBT to embed EE SIM technology into LBT�� world�� best GPS products for immediate purchase throughout Europe and in additional areas around the world.

  EE�� relationship with LBT continues to grow. The companies began their relationship earlier this year when EE launched PocketFinder Personal GPS Locators in their London flagship stores (https://explore.ee.co.uk/pocket-finder). With this latest agreement, LBT now has the capability to sell devices into Europe using a local SIM, thereby greatly reducing the monthly service fee charged to customers.

Best Communications Equipment Stocks To Watch Right Now: LifeLock Inc (LOCK)

LifeLock, Inc., incorporated on April 12, 2005, is a provider of proactive identity theft protection services for consumers and identity risk assessment and fraud protection services for enterprises. It operates in two segments: consumer segment and an enterprise segment. In its consumer segment, the Company offer identity theft protection services to consumers on a monthly or annual subscription basis. In its enterprise segment, it offer identity risk assessment and fraud protection services to enterprise customers who pay the Company based on their monthly volume of transactions with it. It protects its consumer subscribers, whom it refers to as its members, by monitoring identity-related events, such as new account openings and credit-related applications. It also provides remediation services to its members in the event that an identity theft actually occurs. On March 14, 2012, the Company acquired ID Analytics, Inc. In December 2013, the Company announced that it has completed the acquisition of Lemon Inc.

Consumer Business

The Company protects its members by proactively monitoring identity-related events, such as new account openings and credit-related applications, which may present a risk of identity theft. If it detects that a member�� personally identifiable information is being used, the Company sends notifications and alerts, including proactive, near real-time, actionable alerts, to the member via text message, phone call, or e-mail through its LifeLock Identity Alert system that allows the member to confirm valid or unauthorized identity use.

Enterprise Business

The Company delivers on-demand identity risk assessment and authentication information about consumers to its enterprise customers in their daily transaction flows. Its enterprise customers utilize this information in real time to authenticate their customers, assess their risk profile, and enhance the enterprise�� decision making process on which to base account opening, le! nding, credit, and other risk-based decisions. By integrating its services into their business processes, its enterprise customers can reduce potential financial losses from identity fraud. Information generated from the transaction flow at its enterprise customers is transmitted back to its data repositories, which continually enhances the LifeLock ecosystem and helps strengthen the services the Company can provide to its customers in the future.

The Company competes with Experian, Equifax, TransUnion, Affinion, Early Warning Systems, Intersections and LexisNexis.

Advisors' Opinion:

• [By Rick Aristotle Munarriz]

  AFP/Getty Images/Gabriel Bouys Companies can make brilliant moves, but there are also times when things don't work out quite as planned. From a luxury electric car maker ramping up its production to sandwich makers failing to make dough rise, here's a rundown of the week's smartest moves and biggest blunders in the business world. Tesla Motors (TSLA) -- Winner The Model S isn't cheap, but Tesla is selling enough of them to impress investors. Shares of the maker of plug-in electric vehicles raced to a new high after announcing that it delivered 6,892 cars in its latest quarter. Things will get even better in 2014 as Tesla expects to sell and deliver 35,000 vehicles. Tesla will need to ramp up its production -- currently, roughly 600 cars a week -- to closer to 1,000 Model S and new Model X cars by the end of the year. Conn's (CONN) -- Loser It isn't easy running a consumer electronics store these days. Shares of Conn's plunged 43 percent on Thursday after warning that its holiday quarter results will fall well short of its earlier expectations. If that seems like a significant drop for a mere miss, let's dive a little deeper. Conn's also warned that it's suffering from higher loan delinquencies than usual. Conn's provides in-house consumer credit on its appliances, furniture, mattresses, and consumer electronics, so revealing that 8.8 percent of its loan portfolio hasn't made a payment in more than 60 days is problematic. Conn's, which has stores in the Southwest, blames cold weather for disrupting payments, but things are never as simple as that. Conn's was holding up better than its peers that had imploded earlier this year on reports that the holidays weren't so jolly this time around. Now we know that Conn's is merely mortal, and that way too many of its customers last year aren't current on their payments. Candy Crush Saga -- Winner The company behind "Candy Crush Saga" filed to go public this week. Dublin-based King Digital Entertainment is hoping

Best Communications Equipment Stocks To Watch Right Now: Revolution Lighting Technologies Inc (RVLT)

Revolution Lighting Technologies Inc., incorporated on December 16, 1993, designs, manufacture, market and sells commercial grade, light emitting diode (LED) replacement light bulbs and LED-based signage, channel letter and contour lighting products. The Company sells these products under the Seesmart, Array Lighting and Lumificient brand names. The Company operates in two segments: LED replacement lamps and fixtures and LED signage and lighting strips. On December 20, 2012, the Company acquired Seesmart Technologies, Inc., headquartered in Simi Valley, California. In August 2013, the Company announced that it has completed the acquisition of Relume Technologies (Relume). In October 2013, the Company announced that it has acquired a portfolio of general illumination LED lighting products, including several product lines from CMG Energy Solutions (CMG). In November 2013, the Company acquired Tri-State LED.

The Company�� LED replacement lamps and fixtures segment include the Seesmart business and the Array business, which has been integrated with the Seesmart business. The LED signage and lighting strips segment is comprised of the Lumificient business.

Advisors' Opinion:

• [By Stock Investor]

  First up we have Revolution Lighting Technologies, Inc (RVLT). As of last week RVLT had a market cap of $280m. Revenues for the last year came in at $4.4m. The company is averaging a cash burn of approximately $7m per quarter over the last two quarters. If I give the company the benefit of the doubt and assume the $7.5m of investments they made last quarter was a one time event, the cash burn then drops to under $4m per quarter. In March RVLT raised $5m from the issuance of shares priced at $1.17. The company is still in need of additional financing, and with the stock price up 400% in the last three months, it would be wise for them to issue shares right now. This increases the risk for investors dramatically right now.

• [By Paul Ausick]

  Big Earnings Movers: The Walt Disney Co. (NYSE: DIS) is up 2.1% at $68.58 on a good showing for its films but not so much for its TV programming. Molycorp Inc. (NYSE: MCP) is up 1.8% at $4.85 after offering a weakish outlook. Revolution Lighting Technologies Inc. (NASDAQ: RVLT) is up 21.5% at $3.28 after a strong report and reaffirmed solid outlook.

• [By Paul Ausick]

  Without making too much fuss over a small-cap stock, Revolution Lighting Technologies Inc. (NASDAQ: RVLT) is seeing its share price rise by nearly 25% today after reporting results this Friday morning. Yahoo! Finance does not have any estimates for the company, but Revolution posted an operating loss of $3.1 million in the quarter, more than four times worse than its loss in the same period in 2012. Even with adjustments Revolution�� operating loss totaled $1.8 million.

Best Communications Equipment Stocks To Watch Right Now: TomTom NV (TMOAF.PK)

TomTom NV is the Netherlands-based supplier of location and navigation products and services. The Company�� offer includes maps, speed cameras, portable navigation devices (PND), fleet management services (FMS), and smart phone applications. It consists of four customer-facing segments: Consumer, Automotive, Business Solutions and Licensing. The Consumer segment is engaged in the sale of PNDs, speed cameras, maps and other related navigation services to end customers. Automotive sells in-dash navigation solutions, speed cameras, grade maps and services to companies in automotive segment, as well as PNDs for fitness products. The Business solutions segment provides fleet management services and solutions, such as fleet trackers, to fleet owners. Licensing sells digital maps, mobile applications and other content to customers within multiple market segments. The Company operates in over 35 countries worldwide. In July 2013, it acquired Coordina (Gestion Electronica Logistica, S.L.). Advisors' Opinion:

• [By Genesis Housing]

  Nokia's HERE division is worth E1bn assuming a similar market cap as TomTom (TMOAF.PK) but offers significant upside as maps become the next platform for e-commerce. Assuming Nokia's net cash position declines to E2bn at Q3 from E4.1bn in Q2 (given the E1.7bn NSN deal as well as incremental cash burn due to supporting product launches), the combined value of Nokia's Net Cash, HERE division and NSN division is in line with the current market cap of Nokia.

Best Communications Equipment Stocks To Watch Right Now: PositiveID Corp (PSID)

PositiveID Corporation (PositiveID), incorporated in November 2001, is engaged in developing, marketing and selling radio frequency identification (RFID), systems used for the identification of people in the healthcare market. PositiveID is focused on providing health and security identification tools to protect consumers and businesses, operating in two segments: HealthID and ID Security. The Company�� HealthID segment is focused on the development of four products, which includes the GlucoChip, iglucose, Easy Check and the rapid flu detection system. Its ID Security segment includes the identity security suite of products, sold through its NationalCreditReport.com brand and its Health Link personal health record (PHR) business. In July 2011, it completed the sale of substantially all of the assets of NationalCreditReport.com. On May 23, 2011, the Company acquired all of the interest of MicroFluidic Systems (MicroFluidic). In November 2013, the Company sold its interest in VeriTeQ Corporation (VeriTeQ).

HealthID Segment

PositiveID�� HealthID segment product GlucoChip is a glucose-sensing microchip is developed in conjunction with Receptors LLC (Receptors). Iglucose is a self-contained unit that automatically queries a diabetic user�� data-capable glucometer for blood glucose data and sends that data via encrypted text messaging to the iglucose online database. Easy Check is a non-invasive breath glucose detection system, based on the correlation of acetone in exhaled breath to blood glucose levels. The rapid flu detection system is also developed in conjunction with Receptors. The Company�� HealthID segment also includes the VeriMed system, which uses an implantable passive RFID microchip (the VeriChip) that is used in patient identification applications. Each implantable microchip contains a verification number that is read when it is scanned by its scanner.

ID Security Segment

PositiveID�� NationalCreditReport.com business offers consu! mers a range of identity security products and services primarily on a subscription basis. These services help consumers protect themselves against identity theft or fraud and understand and monitor their credit profiles and other personal information, which include credit reports, credit monitoring and credit scores. The Company has Health Link PHR business.

Healthcare Products

PositiveID�� Healthcare products include the GlucoChip, a product that combines a glucose-sensing microtransponder. The Company has partnered with Receptors to develop an in-vivo glucose sensor to detect glucose levels in the human body. In conjunction with Receptors, the Company has completed Phase I and Phase II development of the glucose-sensing microchip and are in Phase III development. The Easy Check breath glucose test, as of January 31, 2012 is under development, is a non-invasive glucose detection system that measures acetone levels in a patient�� exhaled breath. The iglucose system uses machine to machine technology to automatically communicate a diabetic�� glucose readings to the iglucose online database.

MicroFluidic Systems

MicroFluidic specializes in the production of automated instruments for a range of applications in the detection and processing of biological samples, ranging from rapid medical testing to airborne pathogen detection for homeland security. MicroFluidic�� substantial portfolio of related to sample preparation and rapid medical testing applications are the portfolio of virus detection and diabetes management products.

Identity Security Products and Services

National Credit Report.com, LLC (NCRC) is engaged in the consumer provision of credit reports, credit score and credit monitoring products. This business provides a medium for consumers to retrieve and review their credit history, as well as monitor their credit files with one or all three of the major credit reporting bureaus: Experian, Equifax and TransUni! on. The C! ompany�� products and services are offered to consumers on a monthly subscription basis.

Health Link Personal Health Record and Other Applications

Health Link is a patient-controlled, online repository to store personal health information, such as medications, allergies, family history, previous surgeries, vaccinations and lab results. Health Link also connects the patient to a multitude of customized materials, such as personalized health education and online connectivity to caregivers. Patients can also utilize Health Link to connect with numerous Electronic Medical Record (EMR) systems that are accessible through Microsoft HealthVault and Google Health. In conjunction with Raytheon Microelectronics Espana, the Company developed an eight millimetre microchip, which has functionality that is substantially equivalent to the VeriChip.

Advisors' Opinion:

• [By James E. Brumley]

  Ever heard of PositiveID Corp. (OTCMKTS:PSID)? Most people haven't, so don't worry if it's an unfamiliar name. What's surprising is that PSID is still a little unfamiliar to the masses at this stage of the Ebola game. It's not just a worry that we only have to worry about domestically. It's now spreading within the United States, which is a whole different ball game than preventing it from getting to the United States. This presents a real risk of pandemic spreading within our borders. PositiveID can help.

Best Communications Equipment Stocks To Watch Right Now: WiLan Inc (WILN)

WiLAN Inc. (WiLAN), incorporated on May 14, 1992, is a licensing company. WiLAN develops, acquires, and licenses a range of intellectual property that drives products in communications and consumer electronics markets. Through both internal research and development and acquisitions from third parties, the Company has acquired intellectual property in the form of patents and patent applications in many countries that it has licensed to more than 255 companies in telecommunications markets around the world. As of December 31, 2011, WiLAN had a portfolio of approximately 3,000 patents, including issued and pending patents and foreign equivalents. WiLAN has five directly wholly-owned subsidiaries, Wi-LAN Capital Inc. (WiLAN Capital), Wi-LAN International Inc. (WiLAN International), Wi-LAN International Hong Kong Inc. (WiLAN Hong Kong), Wi-LAN International Japan Inc. (WiLAN Japan) and Wi-LAN International Taiwan Inc. In July 2012, it acquired a global portfolio of more than 40 patents and applications from Siemens AG related to telecommunication network management and mobile multimedia. In October 2012, the Company acquired a global portfolio of more than 150 patents and patent applications from Alvarion Ltd. In June 2013, WiLan Inc acquired a portfolio of patents from Cypress Semiconductor Corporation. In November 2013, the Company acquired a portfolio of semiconductor patents from IXYS CH GmbH related to microcontroller technology.

In the Company's licensing business, the Company has signed licenses with companies that sell products utilizing technologies, including CDMA (Code Division Multiple Access-a cellular telecommunications specification); Wi-Fi (the underlying technology of wireless local area networks based on various IEEE 802.11 specifications); WiMAX (Worldwide Interoperability for Microwave Access-a standards-based broadband wireless technology that provides metropolitan area network connectivity based on IEEE 802.16 specifications); LTE (Long Term Evolution-high performance air! interface for cellular mobile communication systems designed to increase the capacity and speed of mobile telephone networks), and ADSL (Asymmetric Digital Subscriber Line-a standards-based access technology that provides broadband Internet access over twisted pair telecommunications wiring). The Company has also signed licenses with companies that sell products utilizing technologies, including DOCSIS (Data Over Cable Service Interface Specifications-a standards-based access technology that provides broadband Internet access over cable networks); Bluetooth (a wireless protocol for exchanging data over short distances between fixed and mobile devices), and V-Chip (a technology that permits the blocking of television programs at a receiver (such as a television, multi-media equipped personal computer or set-top box) by viewers based on ratings information carried on the television signal).

Advisors' Opinion:

• [By Rich Duprey]

  Often accused of being a patent troll,�non-performing entity�WiLAN� (NASDAQ: WILN  ) wrangled a settlement out of Dell (NASDAQ: DELL  ) with details of the deal remaining confidential.

• [By Monica Gerson]

  Breaking news

  Wi-LAN (NASDAQ: WILN) today announced that its Board of Directors has initiated a process to explore and evaluate a broad range of strategic alternatives for the Company to enhance shareholder value. To read the full news, click here. MannKind (NASDAQ: MNKD) today announced that the U.S. Food and Drug Administration (FDA) has acknowledged the resubmission of a New Drug Application (NDA) for AFREZZA庐 (insulin human [rDNA origin]) Inhalation Powder. To read the full news, click here. lululemon athletica (NASDAQ: LULU) today announced that Tara Poseley has been appointed to its Senior Leadership Team as Chief Product Officer. To read the full news, click here. Nice Systems (NASDAQ: NICE) reported a drop in its third-quarter profit. To read the full news, click here.

  Posted-In: Bank of America FOMC US Stock FuturesNews Eurozone Futures Pre-Market Outlook Markets

Best Communications Equipment Stocks To Watch Right Now: Juniper Networks Inc (JNPR)

Juniper Networks, Inc. (Juniper Networks), incorporated on September 10, 1996, designs, develops, and sells products and services that together provide its customers with network infrastructure. It operates in two segments: Infrastructure and Service Layer Technologies (SLT). The Company�� Infrastructure segment primarily offers routing and switching products that are used to control and direct network traffic from the core, through the edge, aggregation, and the customer premise equipment level. Infrastructure products include its Internet protocol (IP) routing, carrier Ethernet routing portfolio, and Ethernet switching portfolio. In addition, the Infrastructure segment offers a complete wireless local area network (WLAN) solution. Its SLT segment offers solutions that meet a range of its customers' priorities, from protecting the users, applications and data on the network itself to providing network services across a distributed infrastructure. Effective September 13, 2013, Juniper Networks, Inc. acquired Contrail Networks Inc.

Brilliant is a supplier of packet-based, network synchronization equipment and monitoring solutions. During the year ended December 31, 2011, the Company introduced its network architecture and fabric technology for the data center, QFabric. It serves the high-performance networking requirements of global service providers, enterprises, and public sector organizations. The Company�� open cross-network software platform includes the Junos operating system (Junos OS), Junos Space network application platform, and Junos Pulse integrated network client. The Company offers a product portfolio that spans routing, switching, security, application access, and mobility device security.

Infrastructure Products

The Company�� T Series core routers are primarily designed for core IP infrastructures and are also being sold into the multi-service environment. Its PTX Series is a large capacity (8 and 16 tera-bits per second) MPLS-optimized packe! t transport switch for the core networks, of content service providers and Tier 1 service providers, with high throughout of packet traffic. The Company�� E Series products are a full featured platform designed for the network edge with support for carrier-class routing, broadband subscriber management services, and a set of IP services. The MX Series is a product family developed to address emerging Ethernet network architectures and services in service provider and enterprise networks. The Company�� EX Series family extends its product portfolio running its Junos OS to address the Ethernet switch market. Ethernet is a used technology, which is used to transport information in enterprise networks. Infrastructure Products also includes QFabric Products and WLAN product.

SLT Products

SLT Products include Services Gateway, Integrated Firewall, and VPN Solutions, Secure Access Appliances, Secure Access Appliances, IDP Series Appliances and Identity and Policy Control Solutions. The Company�� SRX Series of dynamic services gateways, running its Junos software, provides firewall/VPN and combines routing, switching, and security functionality. The series is designed to meet network and security requirements for data center consolidation, rapid managed services deployments, and aggregation of security services. Its firewall and VPN systems and appliances are designed to provide integrated firewall, VPN, and denial of service protection capabilities for both enterprise environments and service provider network infrastructures. These products range from its SSG product series, which combines LAN/WAN routing capabilities with threat management features, such as antivirus, anti-spam, and Web filtering technologies, to its ISG and NetScreen Series firewall and VPN systems, which are designed to deliver security in medium/large enterprises, carrier networks, and data centers.

The Company�� Junos Pulse, Junos Pulse Mobile Security Suite, and SA Series SSL VPN appliances,! designed! for use in companies of all sizes, are used to provide secure access to corporate resources for remote and mobile users from any Web-enabled device, regardless of location. Its portfolio of identity and policy control solutions integrates subscriber privileges, application requirements, and business policies with the IP network infrastructure.

The Company competes with Cisco Systems, Inc. (Cisco), Alcatel-Lucent, Brocade Communications Systems, Inc. (Brocade), Extreme Networks, Inc., Hewlett Packard Company (HP), Huawei Technologies Co., Ltd. (Huawei), Check Point Software Technologies, F5 Networks, Inc., Palo Alto Networks, Inc., and Riverbed Technology, Inc.

Advisors' Opinion:

• [By Monica Wolfe]

  The following information is a highlight of the real-time guru activity we saw this week. To view more information on these gurus, check out their guru portfolios. The ��eal Time Picks��reports the stock purchases and sells that Gurus have made within the prior two weeks. If a Guru makes a purchase or sell of a company in which they own a greater-than 5% stake, SEC regulations require them to report their transaction within two days. This week we saw notable increases and buys in Real Time activity from Kyle Bass (Trades, Portfolio) and Paul Singer (Trades, Portfolio).Kyle Bass (Trades, Portfolio) Over the past week Kyle Bass (Trades, Portfolio) made a notable increase in to Nationstar Mortgage Holdings (NSM). The guru added a total of 3,673,972 shares of the company�� stock. He bought these shares at an average price of $31.27 per share, and since then the price per share has gone up about 5% to $32.80 per share.Bass now holds on to 4,759,610 shares of Nationstar Mortgage holdings, representing 5.26% of the company�� shares outstanding.Bass�� historical holding history as of the close of the fourth quarter 2013:Nationstar Mortgage provides residential mortgage loan services. It services residential mortgage loans throughout the United States. Nationstar is one of the largest servicers in the US, with a residential mortgage servicing portfolio of over $391 billion in unpaid principal balance as of Dec. 31, 2013.Nationstar Mortgage�� historical revenue and net income:The company recently released its fourth quarter and full year financial results which highlighted:- 2013 GAAP EPS of $2.40 on net income of $217 million.- Ending servicing portfolio UPB of $391 billion.- 2013 servicing portfolio growth of 88%.- 2013 return on equity of 25%.- Funded volume of $24 billion in 2013.The company also recently announced that they had received a letter from Benjamin Lawsky, Superintendent of the New York Department of Financial Services, which inquires about Nat

Top 10 Biotech Companies To Buy For 2015

In the health care sector, investors can tap into the full range of the risk spectrum. They can swing for the fences with bets on emerging biotechnology companies set to deliver groundbreaking new drugs, or they can make lower risk plays on “Big Pharma,” hoping these giant drug makers can stay ahead of their patent expiration curve.

Among the lowest risk plays of all in the sector are distribution companies that produce steady growth and returns on trends as simple as increasing utilization.

Henry Schein (NSDQ: HSIC) is a global distributor of health care products, including medical, dental and animal health care supplies with about 35 percent of sales outside of the US. It also offers software systems used to manage finances, educational requirements and other office functions as well as value-added services such as practice design.

Since the company went public in 1995, its sales have grown at an annual compound rate of 17 percent, rising from $616.2 million to $8.9 billion last year. Earnings per share (EPS) have experienced similar growth, up from $0.34 in 1995 to $4.44 in 2012.

Top Financial Companies To Own For 2016: Regeneron Pharmaceuticals Inc.(REGN)

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions in the United States. The company?s commercial product includes ARCALYST (rilonacept) injection for subcutaneous use for the treatment of cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome in adults and children. Its products under Phase III clinical development stage consist of VEGF Trap-Eye, an aflibercept ophthalmic solution developed using intraocular delivery for the treatment of serious eye diseases; ARCALYST for the prevention of gout flares in patients initiating uric acid-lowering treatment; and Aflibercept (VEGF Trap), which is developed in oncology. The company?s earlier stage clinical programs include various human antibodies, such as REGN727 for low-density lipoprotein cholesterol reduction, REGN88 for rheumatoid arthritis and ankylosing spondylitis; REGN668 for atopic dermatitis and asthma; REGN421 and REGN910 for oncology; REGN475 for the treatment of pain; and REGN728 and REGN846. It also conducts preclinical research programs in the areas of oncology and angiogenesis, ophthalmology, metabolic and related diseases, muscle diseases and disorders, inflammation and immune diseases, bone and cartilage, pain, cardiovascular diseases, and infectious diseases. The company distributes its products through third party service providers. It has strategic collaboration with sanofi-aventis Group to discover, develop, and commercialize human monoclonal antibodies; and Bayer HealthCare LLC to develop and commercialize VEGF Trap. Regeneron Pharmaceuticals, Inc. was founded in 1988 and is based in Tarrytown, New York.

Advisors' Opinion:

• [By Traders Reserve]

  Regeneron (REGN) shares could see a big jump in 2014. The big promise in the year is with respect to expansion of its eye treatment product, Eylea. Analysts expect the company to grow profits by more than 50% in 2014. At current prices shares trade for 54 times 2014 estimated earnings. That�� a rich premium, but not nosebleed compared to some momentum stocks. The real potential for growth to be even larger than expected is what turns on the momentum ground and as other rocket ships come back to earth look for this one to keep on climbing.

Top 10 Biotech Companies To Buy For 2015: Vertex Pharmaceuticals Incorporated(VRTX)

Vertex Pharmaceuticals Incorporated engages in discovering, developing, manufacturing, and commercializing small molecule drugs for the treatment of serious diseases worldwide. Its products include telaprevir, a prescription medicine used for the treatment of patients with genotype 1 hepatitis C virus (HCV) infection; and Ivacaftor, a prescription medicine used for the treatment of cystic fibrosis. The company markets its products under the INCIVEK brand name in the United States and Canada; INCIVO brand in the United Kingdom, Germany, France, Sweden, Austria, Finland, Denmark, Switzerland, and Norway; KALYDECO brand in the United States; and TELAVIC brand in Japan. Its drug candidates comprise VX-222, a Phase II clinical trial drug candidate, and ALS-2200 and ALS-2158, a Phase I clinical trial drug candidates that are designed to inhibit the replication of HCV; VX-809 and VX-661, a Phase II clinical trial drug candidates that improve the function of defective cystic fibro sis; VX-509, a Phase II clinical trial drug candidate for the treatment of patients with rheumatoid arthritis and other immune-mediated inflammatory diseases; VX-765, a Phase II clinical trial drug for the treatment of epilepsy; and VX-787, an investigational drug candidate for the treatment of influenza A. The company was founded in 1989 and is headquartered in Cambridge, Massachusetts.

Advisors' Opinion:

• [By Ben Levisohn]

  Sovaldi selling way beyond our expectations. The initial prescription data are so massively outperforming even the biggest weeks Incivek ever had, we believe any reasonable comparison between the two drugs would indicate that U.S. sales in 2014, alone, are going to exceed $5 billion. In 4Q11, Vertex (VRTX) recognized $458 million in Incivek sales and WK reported 11,409 NRx. Sovaldi is already pacing more than 2x that volume in 1Q14. Sovaldi also has ~70% price premium over Incivek. There is almost no way barring an extreme reduction in volume over the next few weeks that Gilead won’t hit at least $1 billion in sales in 1Q14 (consensus is at $336 million), and that really only accounts for U.S. sales. While we expect a slower uptake ex-US, we note that historical Incivo sales indicate that there is likely to be an additional $1 billion in Sovaldi sales in 2014 coming from ex-U.S. territories. We believe this volume implies that next year’s sofosbuvir/ledipisvir sales are not only set to be the best launch ever, but exceed the highest single year sales of any pharmaceutical product in history…As a result of our model changes, we are raising our price target to $103 and elevating the stock to Outperform.

• [By Northwest Trader]

  That was the case until Vertex's (VRTX) successful launch of VX-770 (Kalydeco) in January of 2012.

  Kalydeco (Ivacaftor) addresses the G551D mutation via CFTR modulation (potentiator), and is an orphan drug with a steep price tag of $294,000 per year. As CF is a chronic disease, this represents a potential gross revenue of roughly 340 million dollars per year.

• [By Garrett Cook]

  Vertex Pharmaceuticals (NASDAQ: VRTX) shares shot up 42.73 percent to $95.07 after the company reported that its two phase 3 studies of Lumacaftor in combination with ivacaftor met the primary endpoint.

• [By Sean Williams]

  Vertex Pharmaceuticals (NASDAQ: VRTX  ) suffered through an unpleasant week, with shares down 9% after it announced a partial clinical hold on Friday for its all-oral hepatitis-C drug, VX-135. The drug, which is currently in midstage trials, was placed on clinical hold by the FDA after it noted elevated, but reversible, liver enzyme levels in patients receiving the 400mg dose with ribavirin. To me this looks like a precautionary hold, but it will be perceived as painful, since it puts Vertex's oral hepatitis-C medication that much further behind its competition. Kalydeco is becoming the future of Vertex with regard to its potential to treat various mutations of cystic fibrosis, so I wouldn't worry too much about this minor setback with VX-135.

Top 10 Biotech Companies To Buy For 2015: Flexion Therapeutics Inc (FLXN)

Flexion Therapeutics, Inc. (Flexion Therapeutics), incorporated on November 5, 2007, is a pharmaceutical company focused on the development and commercialization of injectable pain therapies. The Company is targeting anti-inflammatory and analgesic therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis, a type of degenerative arthritis, referred to as OA. The Company�� portfolio of small molecule product candidates addresses the OA pain treatment spectrum, from moderate to severe pain. The Company�� product candidate, FX006, is an injectable intra-articular, meaning in the joint, sustained-release treatment for patients with moderate to severe OA pain. It is developing two additional product candidates, FX007 for post-operative pain and FX005 to treat end-stage OA patients. FX007 is a locally administered TrkA receptor antagonist for persistent relief of post-operative pain, including in patients who have received total joint replacement, also referred to as total joint arthroplasty (TJA). Its product candidates are designed to deliver established anti-inflammatory and analgesic effects directly to the site of disease, optimizing sustained local drug concentration to achieve a durable and clinically meaningful response. These product candidates are also designed to limit systemic exposure to the drugs and minimize systemic toxicities.

FX006 - Front Line IA Therapy for Patients with Moderate to Severe OA Pain

FX006 is a steroid, triamcinolone acetonide (TCA), formulated for sustained-release, delivered through intra-articular (IA) injection and designed to treat moderate to severe OA pain. FX006 combines commonly administered TCA with poly lactic-co-glycolic acid (PLGA), its injectable IA sustained-release technology. As of January 8, 2014, two clinical trials had been conducted to test FX006 against immediate-release TCA injection. FX006 has been studied in two clinical trials, in which a total of 196 patients received FX006! and a total of 56 patients received immediate-release TCA: Study FX006-2011-001 and Study FX006-2011-002.

FX007-For Post-Operative Pain

FX007 is a small molecule TrkA receptor antagonist that is in development for the persistent relief of post-operative pain. TrkA is the receptor for nerve growth factor, commonly known as NGF, a small peptide that is released following tissue injury. NGF binds to TrkA on the surface of pain sensing neurons and renders these cells more responsive to external stimuli.

FX005-For End-Stage OA Pain

FX005 is intended as therapy for patients with end-stage OA pain, particularly those patients awaiting TJA, as an alternative to opioids. FX005 is a p38 MAP, or mitogen-activated protein, kinase inhibitor formulated for sustained-release delivered through IA injection, which is designed to have both analgesic and anti-inflammatory benefits without the systemic side effects of oral p38 MAP kinase inhibitors. p38 MAP kinase is an enzyme in an inflammatory cascade that upregulates in response to stress and culminates in the elaboration of multiple proinflammatory cytokines, including interleukin 1 and tumor necrosis factor, as well as enzymes like matrix metalloproteinases that have the potential to destroy cartilage. In other studies, multiple oral p38 MAP kinase inhibitors have been evaluated in inflammatory diseases and pain and, while efficacy has been demonstrated, serious toxicity affecting multiple organ systems has been frequently observed. FX005 has completed a Phase-II A clinical trial, in which 70 patients were randomized to FX005 and 70 patients were randomized to placebo.

The Company competes with Fidia Farmaceutici S.p.A, Ampio Pharmaceuticals, Inc., Carbylan BioSurgery, Inc., Merck Serono and Allergan, Inc., Pacira Pharmaceuticals, Janssen Pharmaceuticals, Inc. and Johnson & Johnson.

Advisors' Opinion:

• [By John Udovich]

  It�� a new year and the first one and a half trading weeks of 2014 has not disappointed biotech investors as the sector and mid cap or small cap biotech or�pharma stocks like Intercept Pharmaceuticals Inc (NASDAQ: ICPT), Epizyme Inc (NASDAQ: EPZM), Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) and TNI BioTech Inc (OTCQB: TNIB) either surging or producing some news plus there have been IPO filings for future listings for�Flexion Therapeutics (NASDAQ: FLXN), Aldexa Therapeutics (NASDAQ: ALDX), Retrophin (NASDAQ:�RTRX) and Dicerna Pharmaceuticals (NASDAQ: DRNA). Consider the following news so far this year:

• [By John Udovich]

  The start of 2014 shows that biotech is still a hot area with the sector along with small cap biotech stocks like AMAG Pharmaceuticals, Inc (NASDAQ: AMAG), Mast Therapeutics Inc (NYSEMKT: MSTX), Cell Therapeutics Inc (NASDAQ: CTIC), Imprimis Pharmaceuticals Inc (NASDAQ: IMMY) and TNI BioTech (OTCMKTS: TNIB) producing news or returns�plus Auspex Pharmaceuticals (NASDAQ: ASPX), Cara Therapeutics (NASDAQ: CARA), Egalet (NASDAQ: EGLT), Flexion Therapeutics (NASDAQ: FLXN) and Ultragenyx Pharmaceutical (NASDAQ: RARE) are among the (many�� planned biotech IPOs that have recently been announced publicly:

Top 10 Biotech Companies To Buy For 2015: Osiris Therapeutics Inc.(OSIR)

Osiris Therapeutics, Inc., a stem cell company, focuses on the development and marketing of therapeutic products to treat various medical conditions in the inflammatory, autoimmune, orthopedic, and cardiovascular areas. It operates in two business segments, Therapeutics and Biosurgery. The Therapeutics segment focuses on developing biologic stem cell drug candidates from a readily available and non-controversial source, adult bone marrow. The Biosurgery segment works to harness the ability of cells and novel constructs to promote the body's natural healing. This segment focuses on developing biologic products for use in surgical procedures. The company?s lead biologic drug candidate is Prochymal, which is in phase 2 and 3 clinical trails for various indications, including acute graft versus host disease (GvHD), Crohn's disease, acute myocardial infarction, type 1 diabetes, pulmonary disease, and gastrointestinal injury resulting from radiation exposure. Its biologic drug candidates also include Chondrogen, a preparation of adult mesenchymal stem cells that is in phase 2 clinical trials for osteoarthritis and cartilage protection. The company has collaboration agreements with Genzyme Corporation for the development and commercialization of Prochymal and Chondrogen in various countries except in the United States and Canada. It also has a partnership with Juvenile Diabetes Research Foundation for the development of Prochymal as a treatment for the preservation of insulin production in patients with newly diagnosed type 1 diabetes mellitus. Osiris Therapeutics, Inc. was founded in 1992 and is headquartered in Columbia, Maryland.

Advisors' Opinion:

• [By Alexander Maxwell]

  One of the companies attempting to develop a better treatment for chronic diabetic foot ulcers is Osiris Therapeutics� (NASDAQ: OSIR  ) . Earlier this month, Osiris shares more than doubled as the company announced positive data for its CDFU drug Grafix. The study results were very impressive to say the least; the study was stopped early due to the overwhelming efficacy exhibited by the treatment. A main highlight is the fact that 62% of Grafix patients had their wound closed at 12 weeks, compared to only 21% of patients using conventional methods. Clearly, the efficacy in this endpoint was overwhelming. Grafix also achieved all of the secondary endpoints for the trial, and more importantly demonstrated a relatively benign safety record.�

• [By Lauren Pollock]

  Osiris Therapeutics Inc.(OSIR) said Friday a proposed ruling from the Centers for Medicare and Medicaid Services won’t immediately affect reimbursements for its Grafix stem-cell product. The regenerative medicine company said Grafix will maintain its current reimbursement status — also called transitional pass-through status — potentially through late 2015.

• [By Maxx Chatsko]

  Additionally, stem cell therapies have remained elusive as the industry's ultimate Holy Grail. Osiris (NASDAQ: OSIR  ) received Canadian approval for the world's first stem cell drug, Prochymal, for children battling acute graft-versus-host disease, or GvHD, last year. The approval meant more symbolically than to the bottom line, but it definitely put the potential of stem cells front and center for investors.

Top 10 Biotech Companies To Buy For 2015: ArQule Inc.(ARQL)

ArQule, Inc., a clinical-stage biotechnology company, engages in the research and development of cancer therapeutics directed toward molecular targets and biological processes. Its lead product ARQ 197 is non-adenosine triphosphate competitive inhibitor of the c-Met receptor tyrosine kinase, which is being evaluated as monotherapy and in combination therapy in a Phase II clinical development program that includes trials in non-small cell lung cancer, c-Met-associated soft tissue sarcomas, pancreatic adenocarcinoma, hepatocellular carcinoma, germ cell tumors, and colorectal cancer. The company is also developing ARQ 621, a Phase I program focused on inhibition of the Eg5 kinesin spindle protein. Its clinical stage products include ARQ 501, ARQ 761, and ARQ 171, which are designed to kill cancer cells selectively while sparing normal cells through the direct activation of DNA damage response/checkpoint pathways. In addition, the company involves in pre-clinical development o f B-RAF and AKIP Kinase inhibitors. The company has collaborations with Kyowa Hakko Kirin Co., Ltd. and Daiichi Sankyo Co., Ltd. ArQule, Inc. was founded in 1993 and is headquartered in Woburn, Massachusetts.

Advisors' Opinion:

• [By Roberto Pedone]

   

  ArQule (ARQL), a clinical-stage biotechnology company, researches and develops cancer therapeutics. This stock closed up 3.4% to $1.49 in Thursday's trading session.

   

  Thursday's Range: $1.44-$1.54
  
  52-Week Range: $1.29-$2.94
  
  Thursday's Volume: 908,000
  
  Three-Month Average Volume: 567,811

   

  From a technical perspective, ARQL jumped higher here right above some near-term support at $1.40 with above-average volume. This move briefly pushed shares of ARQL back above its 50-day moving average of $1.53, before the stock closed just below that level at $1.49. This move is starting to push shares of ARQL within range of triggering a near-term breakout trade. That trade will hit if ARQL manages to take out some near-term overhead resistance levels at $1.54 to $1.60 with high volume.

   

  Traders should now look for long-biased trades in ARQL as long as it's trending above some near-term support levels at $1.40 or at $1.35 and then once it sustains a move or close above those breakout levels with volume that hits near or above 567,811 shares. If that breakout hits soon, then ARQL will set up to re-test or possibly take out its next major overhead resistance levels at $1.66 to $1.78, or even $1.90 to $2.

   

Top 10 Biotech Companies To Buy For 2015: Celsion Corporation(CLSN)

Celsion Corporation, an oncology drug development company, develops and commercializes targeted chemotherapeutic oncology drugs based on its proprietary heat-activated liposomal technology. The company is developing its lead product, ThermoDox that is in Phase III clinical trial for primary liver cancer; and in phase II clinical trial for treatment of recurrent chest wall breast cancer. It has a license agreement with Yakult Honsha to commercialize and market ThermoDox for the Japanese market. The company also has a license agreement with Duke University under which it received exclusive rights to commercialize and use Duke's thermo-liposome technology. In addition, Celsion Corporation has a joint research agreement with Royal Phillips Electronics to evaluate the combination of Phillips' high intensity focused ultrasound with its ThermoDox to determine the potential of this combination to treat a range of cancers. The company was founded in 1982 and is based in Columbia, M aryland.

Advisors' Opinion:

• [By EquityOptionsGuru]

  The Prolieve Thermodilatation System was actually developed by the current management of Medifocus while employed at Celsion Corporation (NASDAQ:CLSN). The system was also jointly developed with Boston Scientific (NYSE:BSX) before being acquired by Medifocus in July 2012. Prolieve has already received FDA approval, is currently generating revenue, and is the only in office alternative to drug therapy. The system essentially uses microwave energy to treat Benign Prostatic Hyperplasia (BPH), which is a non-cancerous enlargement of the prostate gland that typically affects men over the age of 50. The Prolieve device works by compressing and heating prostatic tissue that may be blocking the flow of urine. This particular treatment option offers patients several benefits including the following:

Top 10 Biotech Companies To Buy For 2015: Conatus Pharmaceuticals Inc (CNAT)

Conatus Pharmaceuticals Inc., incorporated on July 13, 2005, is a biotechnology company focused on the development and commercialization of medicines to treat liver disease. The Company is developing its lead compound, emricasan, for the treatment of patients in orphan populations with chronic liver disease and acute exacerbations of chronic liver disease. The Company has designed a clinical program to demonstrate the therapeutic benefit of emricasan across the spectrum of fibrotic liver disease. The Company�� initial development strategy targets indications for emricasan with high unmet clinical need in orphan patient populations, such as patients with acute-on-chronic liver failure (ACLF), chronic liver failure (CLF), and patients who have developed liver fibrosis post-orthotopic liver transplant due to Hepatitis C virus infection (HCV-POLT).

The Company has completed two placebo-controlled Phase II trials in patients with liver disease showing reductions in ALT levels that occur rapidly, within as little as one day after initiation of therapy, and are maintained throughout the treatment period. In the Company�� 204-patient Phase 2b trial, it also measured cCK18, an important biomarker of apoptosis and disease severity. Emricasan has been generally well-tolerated in all of the clinical studies. As of July 23, 2013, the Company had not generated any revenue.

Advisors' Opinion:

• [By John Udovich]

  While Intercept Pharmaceuticals Inc (NASDAQ: ICPT) surged earlier this year and Achillion Pharmaceuticals, Inc (NASDAQ: ACHN) has surged this week after Merck & Co. Inc (NYSE: MRK) agreed to purchase hepatitis stock�Idenix Pharmaceuticals Inc (NASDAQ: IDIX) at a 239% premium, it seems the herd has realized that small cap Conatus Pharmaceuticals Inc (NASDAQ: CNAT) is also a liver disease stock as shares suddenly surged 56.69% on no apparent company news. But just what is�Conatus Pharmaceuticals and is it worth taking a chance on?

• [By John Udovich]

  Recent IPO�FibroGen Inc (NASDAQ: FGEN) surged 22.96% today, reportedly after the journal Hepatology published the results of a workshop between the FDA and the American Association for the Study of Liver Disease (AASLD) which laid out criteria for a phase three study of a treatment for non-alcoholic steatohepatitis (NASH)���meaning its worth taking a closer look at the stock along with the performance of potential small cap or mid cap liver disease stock peers like Conatus Pharmaceuticals Inc (NASDAQ: CNAT), Intercept Pharmaceuticals Inc (NASDAQ: ICPT) and Raptor Pharmaceutical Corp (NASDAQ: RPTP) which rose 24.35%, 10.98% and 2.02%, respectively. According to Investors Business Daily, NASH (the more serious version of fatty liver disease) is potentially an enormous market with about 6 million�US patients but the�lack of previous treatments had left it unclear how the FDA would measure success against the disease while FibroGen Inc doesn't yet have a NASH human trial in the works, it has said it hopes to start one for its lead candidate FG-3019 (its in mid-stage trials for pulmonary fibrosis and liver fibrosis due to hepatitis B infection).

Best Managed Healthcare Companies To Watch For 2015

United Continental's (NYSE: UAL  ) United Airlines needs a few more airplanes -- and it's buying them from Brazil.

On Monday, Embraer (NYSE: ERJ  ) announced that it has signed a firm order agreement to sell UA 30 of its Embraer 175 regional jets, along with options to buy 40 more. At list prices, and assuming all options are exercised, the deal would be worth $2.9 billion to Embraer.

Announcing the deal, Embraer emphasized its long-standing relationship with the airline, which was Embraer's "launch customer" (the first airline to sign on the dotted line to buy its planes) for the ERJ 145 airliner back in 1996, and has been buying Embraer planes since the 1980s. (This was all pre-merger. At the time, UA was still known as Continental.)

United says it will fly the new planes under its United Express brand, and will configure them as 76-seaters offering a large first-class section, and larger overhead storage bins. The planes will replace older 50-seat aircraft -- and in addition to carrying more customers, will also be more fuel efficient.

Best Safest Stocks To Own Right Now: Universal Health Services Inc. (UHS)

Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, behavioral health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers. The company�s hospitals offer various services comprising general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, pediatric services, pharmacy services, and/or behavioral health services. As of February 24, 2012, it owned and/or operated 25 acute care hospitals and 198 behavioral health centers located in 36 states, Puerto Rico, and the U.S. Virgin Islands, as well as Washington, D.C. The company also operates six surgical hospitals, and surgery and radiation oncology centers located in four states and Puerto Rico. Universal Health Services, Inc. was founded in 1978 and is headquartered in King of Prussia, Pennsylvania.

Advisors' Opinion:

• [By Ben Levisohn]

  Tenets plunge has helped drag other healthcare stocks lower.�Community Health (CYH) has dropped 3.6% to $42.21,�HCA Holdings (HCA) has fallen 2.1% to $46.72 and�Universal Health Services�(UHS) is off 1% at $80.59.

Best Managed Healthcare Companies To Watch For 2015: eGain Corp (EGAN)

eGain Corporation (eGain), formerly eGain Communications Corporation, incorporated in September 1997, provides multichannel customer service and knowledge management software for in-house or cloud deployment. The Company�� application suite, eGain Service, is available through both licensed and hosted models. It includes integrated applications for social customer service, Web self-service, e-mail management, paper and fax management, chat, co-browsing, short message service (SMS), call tracking and resolution, proactive notifications, cross-channel knowledge management, case management and service fulfillment. These robust applications are built on the eGain OpenCIH platform. The eGain OpenCIH platform enables end-to-end service process management and multichannel, multisite contact center management, and includes certified out of the box integrations with call center, content and business systems. Its applications and platform are built on a service-oriented architecture. It serves a global customer base across a range of industry sectors, including telecommunications, financial services, insurance, outsourced services, retail, technology, manufacturing and consumer goods.

Products and Services

eGain Service 9 is a customer service management solution. It consists of a multichannel customer interaction hub (CIH) platform, eGain OpenCIH Platform, and the eGain Web Customer Experience Suite and the eGain Unified Contact Center Suite, which includes applications for social customer service, Web self-service, and the contact center. The eGain OpenCIH Platform centralizes business rules, interactions, knowledge bases, workflow, analytics, administration and integrations in one common foundation. eGain Mail is a solution for processing inbound customer e-mails and providing mission-critical e-mail customer service. Secure messaging, lifecycle audits and real-time archival are some of the features that provide its customers e-mail management platform for their enterprises. Addi! tional modules include eGain Fax to route, track and respond to faxes with the same infrastructure that is used to handle e-mails and Web form submissions.

The Company�� eGain CallTrack is a phone call logging system. Together with eGain KnowledgeAgent, it provides an integrated solution for phone call logging, tracking and resolution, as well as follow-on task management for service fulfillment. eGain Chat gives contact center agents a range of tools for serving customers in real-time. eGain Chat supports two-way, follow me Web browsing so that agents and customers can lead each other to specific Web pages. Its eGain CoBrowse enables contact center agents to provide live collaboration options to online customers and prospects. It gives companies the ability to deliver real-time assistance. The capabilities include enabling the agent and the customer to fill out forms together, creation of business rules for specific Web pages, and allowing phone agents to provide experience by conducting a co-browse session.

The Company�� eGain SelfService is a solution supporting dynamic frequently asked questions (FAQs), topic-based browsing, natural language search, guided help, virtual assistant technology and case tracking. eGain SelfService offers multi-access self-service capabilities built on a collaborative knowledge management framework within eGain OpenCIH Platform. The modules of this solution are eGain Portals, eGain Guided Help and eGain MessageCenter. eGain Portals deliver a secure and personalized Web self-service gateway, through which customers can retrieve information. This online customer service portal delivers to customers the personal information they want, the way they want to see it, and when they want to see it. Customers can view FAQs, manage their own accounts, review open service tickets, and review their communications with the company within a secure, personalized environment. Its eGain Guided Help gives customers interactive access to the company�� knowl! edge base! , allowing them to find answers and troubleshoot problems by themselves at their convenience. It uses patented search and reasoning technology, coupled with natural language and advanced linguistic processing to search, suggest additional questions and recommend solutions.

The Company�� eGain MessageCenter enables secure and authenticated messaging between a business and its customers. eGain MessageCenter is a secure Web-based portal for customers to read confidential messages, including attachments. Based on a business-configurable option, agent responses to customer inquiries are automatically replaced with a dynamically generated universal resource locator (URL), which directs the customers to the eGain MessageCenter where they authenticate themselves to read the message details. Customers can also send messages to the business through this secure site. All messages are stored within the eGain Platform as part of the multichannel customer history. Its eGain Chatbot is used to create virtual assistants to engage Website visitors, answer their queries, escort them on the Website, and escalate seamlessly to live agents. Chatbots help deflect phone calls to Web self-service, provide memorable and brand-aligned customer service experiences, and increase online sales conversion.

The Company�� eGain Social helps a business monitor the Web and social media sites for conversations about itself. It enables the business to identify and respond to customer inquiries or complaints. It also helps harvest useful content from experts in these channels and develops it into knowledge base articles that can be shared with their other customers. Its eGain Adviser empowers agents handle complex customer interactions. Agents receive guided help for providing contextual up-sell and cross-sell, follow-on service fulfillment and value-added advice through conversations that are compliant with regulations. The solution includes a user interface, integrated workflow and interactive process guida! nce, powe! red by the eGain Inference Reasoning Engine.

The Company�� eGain KnowledgeAgent uses patented search and reasoning technology coupled with natural language and advanced linguistic processing to search, suggest additional questions, and recommend solutions. This solution, in conjunction with eGain Content Adapter, also allows agents to access information stored in external systems. Its eGain IVR enables phone self-service experiences by adding intelligence to interactive voice response, (IVR) and unifying it with other interaction channels, including Web self-service. It offers intelligent dialogs driven by eGain�� case-based reasoning technology and seamless movement across channels.

The Company�� eGain Notify is a flexible, easy-to-use application for managing and delivering automatic reminders, alerts, and updates at all stages of the customer relationship cycle. It is used to provide proactive customer service by sending alerts to customers through multiple interaction channels, such as e-mail, phone and SMS. Its eGain AutoClassify enables companies to increase response turnaround and improve problem resolution by categorizing and routing incoming e-mail and other inquiries. It can also be set up to provide auto-suggestions and auto-responses. eGain AutoClassify understands the customer�� issue and routes inquiries to queues based on categories and the confidence level assigned to those categories. Customer interactions can be placed into multiple independent categories.

The Company�� eGain AutoWorkflow enables businesses to automate complex fulfillment processes that require little or no agent interaction once initiated. Tasks initiated from either e-mails, Webforms, or time-driven processes are automatically handled using the capabilities of the eGain Workflow engine. Its eGain SME is an enterprise collaboration tool that allows subject matter experts (SMEs), to participate in the process of resolving customer queries. SMEs, both internal in the contact ! center an! d external in other departments or companies, are able to fully participate in both solving ongoing problems and suggesting new solutions for inclusion in the knowledge base.

The Company�� eGain Adapters include a set of out-of-the-box integration modules for connecting eGain applications with content repositories, call center telephony solutions, databases and business applications. Its offers three integration modules: eGain Content Adapter, eGain CTI Adapter, and eGain Data Adapter. Its eGain Widgets (Web and Mobile) provides contextual access to the knowledge base and customer accounts from various parts of the businesses��Websites, as well as mobile interfaces.

eGain OnDemand

eGain OnDemand, the software as a service version of the Company�� software suite, is a robust and scalable solution that is used by enterprises to build customer interaction hubs. It hosts applications on servers located in its third party SAS 70 Type II data center. The hosting solution allows rapid deployment of eGain products, including seamless secure access to customer�� in-house data systems; round the clock management of infrastructure, security, servers, operating systems and databases; management systems to monitor servers and applications allowing for availability and performance; easy migration from eGain OnDemand to in-house option and vice-versa. Its value-added services include e-mail spam and virus cleaning, post office services, virtual private networks, remote data access, encrypted backups, and test/reporting/warm spare servers.

eGain SLaaS

eGain SLaaS, the solution-as-a-service version of the Company�� software suite. It is designed to take the risk out of mission-critical customer interaction software deployments and enables companies to validate and realize business value with usage-based pricing and no long-term contracts.

Consulting and Education Services

The Company�� global professional services ! organizat! ion provides consulting and education services designed to facilitate customer success and build customer loyalty. Its consulting services group offers rapid implementation services, custom solution development and systems integration services. It provides these services independently or in partnership with systems integrators who have developed consulting expertise on its platform. The Company�� consulting strategy is to increase margins by providing customers with a range of pre-packaged solutions built on top of our product line.The Company�� education services group provides a range of basic and customized training programs to its customers and partners. Training programs are offered either in-person at the customer site, or at one of its global training centers.The Company�� education services strategy is to provide training and delivery methods for its customers and partners.

eGain Customer Support Service

The Company offers a range of support services designed to rapidly respond to inquiries. Its technical support services are available to customers globally under maintenance agreements. Its customer support service strategy is to provide customer support account managers for large enterprise customers. The customer support service team uses eGain�� own software suite to provide services to its customers through customer support service centers located in California, the United Kingdom, and India.

The Company competes with Art Technology Group, Inc., Avaya, Inc., Consona Corporation, Alcatel, InQuira, Inc., Kana Software, Inc., Live Person, Inc., nGenera Corporation, RightNow Technologies, Inc., Microsoft Corporation, Oracle Corporation, Salesforce.com Inc. and SAP Inc.

Advisors' Opinion:

• [By John Udovich]

  Small cap cloud contact software provider Five9 Inc (NASDAQ: FIVN) saw a small pop when it debuted in an IPO last Friday but its now trended back down to its debut price, meaning its worth taking a closer look at the stock along with some potential peers or benchmarks like Incontact Inc (NASDAQ: SAAS), eGain Corp (NASDAQ: EGAN) and LivePerson, Inc (NASDAQ: LPSN).

• [By Monica Gerson]

  eGain (NASDAQ: EGAN) shares fell 3.76% to reach a new 52-week low of $6.40. eGain's trailing-twelve-month ROE is -8.92%

  Aeropostale (NYSE: ARO) shares tumbled 6.81% to reach a new 52-week low of $4.57. Aeropostale shares have dropped 65.05% over the past 52 weeks, while the S&P 500 index has gained 15.37% in the same period.

Best Managed Healthcare Companies To Watch For 2015: CGG SA (CGG)

CGG SA, formerly Compagnie Generale de Geophysique-Veritas, is a manufacturer of geophysical equipment and a provider of a range of seismic services in data acquisition and processing both onshore and offshore, principally to clients in the oil and gas exploration and production industry. The Company operates in two segments: Services and Equipment.

Services

The services segment includes land contract, marine contract, multi-client land and marine, and processing, imaging and reservoir. The land contract includes seismic data acquisition for land, transition zones and shallow water undertaken by the Company on behalf of a specific client. The marine contract includes seismic data acquisition offshore undertaken by the Company on behalf of a specific client. The multi-client land and marine includes seismic data acquisition undertaken by the Company and licensed to a number of clients on a non-exclusive basis. The processing, imaging and reservoir includes processing, imaging and interpretation of geophysical data, data management and reservoir studies for clients.

Land seismic acquisition includes all seismic surveying techniques where the recording sensor is either in direct contact with, or in close proximity to, the ground. The Company�� land business line offers integrated services, including the acquisition and on site processing of seismic data on land, in transition zones and on the ocean floor (shallow water and seabed surveys). It undertakes land surveys with both a contract and multi-client basis. The land operations include surveying and recording crews. Surveying crews lay out the lines to be recorded and mark the sites for shot-hole placement or equipment location. Recording crews produce acoustic impulses and use recording units to synchronize the shooting and record the seismic signals through geophones.

The Company provides a range of three-dimensional (3D) marine seismic services, principally in the Gulf of Mexico, the North Sea an! d off the coasts of West Africa and Brazil, as well as in the Asia-Pacific region. As of December 31, 2011, the Company had a fleet of 19 vessels, including 11 three dimension (3D) high capacity vessels (12 or more streamers), two 10 streamer 3D vessels, three eight streamer 3D vessels and three 3D/two dimension (2D) vessels of lower capacity. Marine seismic surveys are conducted through the deployment of submersible cables (streamers) and acoustic sources (airguns) from marine vessels.

Seismic data processing operations transform seismic data acquired in the field into 2D cross-sections, or 3D images of the earth�� subsurface or four-dimensional (4D) time-lapse seismic data using Geovation and Hampson-Russell software, or third party applications. These images are then interpreted by geophysicists and geologists for use by oil and gas companies in evaluating prospective areas, selecting drilling sites and managing producing reservoirs. The Company provides seismic data processing and reservoir services through the network of data processing centers and reservoir teams located worldwide. As of December 31, 2011, it operated 43 worldwide processing and imaging centers, including 13 dedicated client centers.

Equipment

The Company conducts its equipment development and production operations through Sercel and its subsidiaries. Sercel operates five seismic equipment manufacturing facilities, located in Nantes and Saint Gaudens in France, Houston, Singapore and Alfreton in England. In China, Sercel operates through Hebei Sercel-JunFeng Geophysical Equipment Co. Ltd, based in Hebei. Sercel offers and supports worldwide a range of geophysical equipment for seismic data acquisition, including seismic recording equipment, software and seismic sources, and provides its clients with integrated solutions. Sercel�� principal product line is seismic recording equipment, particularly the 400 family of recording systems, the 408UL and the 428XL. Sercel also markets for vibros! eismic ve! hicles and for vibrator electronic systems (VE 464). Sercel develops and produces a range of geophysical equipment for seismic data acquisition and other ancillary geophysical products, such as geophones, cables and connectors.

The Company competes with WesternGeco, Global Geophysical Services, BGP, Geokinetics, PGS, Fugro and Ion Geophysical Inc.

Advisors' Opinion:

• [By Vanina Egea]

  Baker Hughes has seen greater activity, especially through new partnerships. With CGG (CGG), the company has signed a long-term agreement to provide RoqSCAN technology, a real-time, fully portable, quantitative and automated rock properties and mineralogical analyzer. Also, the firm will acquire Weatherford (WFT)'s pipeline and specialty services business through one of its subsidiaries. Last, the business has signed a letter of intent to develop integrated well completion solutions with TMK.

Best Managed Healthcare Companies To Watch For 2015: TherapeuticsMD Inc (TXMD)

TherapeuticsMD, Inc., incorporated in 1907, promotes, distributes and sells certain products developed and sold by Spectrum Health Network, Inc. (Spectrum) relative to its digital media network. Through the license agreement, the Company focuses on multispecialty group practices and independent physician associations (IPAs) to sell them subscriptions for software, hardware and content developed for and distributed by Spectrum. Spectrum sells its network to IPAs for equipment and installation. On October 4, 2011, the Company acquired VitaMedMD, LLC (VitaMedMD). As a result of the acquisition, VitaMedMD became a wholly owned subsidiary of the Company.

VitaMedMD is a specialty pharmaceutical company, VitaMed is focused on providing products to the women�� health market. The Company focuses on market both over-the-counter (OTC) and prescription nutritional supplements, drugs, medical foods and other medical products through pharmacies and its Web-site. Its brand includes a range of products for women�� health and associated with pregnancy, child birth, nursing, post birth and menopause. Its OTC product line available through its Website includes prenatal vitamins, DHA, iron supplements, calcium supplements, Vitamin D supplements, women�� multivitamins, natural (non-hormonal) menopause relief, and scar reduction creams. In March 2012, the Company launched its first prescription-only prenatal vitamin, vitaMedMD Plus Rx.

vitaMedMD Plus Prenatal Multi-Vitamin + DHA is a two pill combo pack that contains 18 essential vitamins and minerals and 300 milligrams (mg) of life�� DHA. vitaMedMD is a single dose daily multivitamin that provides 14 vitamins, minerals and 200 mg of vegetarian, plant-pure life�� DHA. vitaMedMD Plus Rx is a product with a single-dose combo-pack containing one prenatal vitamin tablet with Quatrefolic Acid. vitaMedMD Plus Rx is a product with a single-dose daily multivitamin containing Quatrefolic Acid. vitaMedMD Iron-150 is a iron replacement supplement. ! vitaMedMD Menopause Relief with Lifenol Plus Bone Support offers a natural solution for hot flashes, night sweats and mood disturbances. vitaMedMD Calcium + Vitamin D is a dietary supplements that help replenish and maintain beneficial levels of Vitamin D. vitaMedMD Stretch Mark Body Cream contains naturally-derived ingredients, including Peptides, Shea Butter, Sweet Almond Oil and Fruit Extracts, that hydrate, soothe and pamper skin to make it softer, smoother and younger-looking.

Advisors' Opinion:

• [By Roberto Pedone]

  One under-$10 specialty pharmaceutical player that's starting to trend within range of triggering a big breakout trade is TherapeuticsMD (TXMD), which is focused on the sales, marketing and development of branded and generic pharmaceutical and OTC products primarily for the women's health care market. This stock has been in play with the bulls so far in 2013, with shares up 56%.

  If you take a look at the chart for TherapeuticsMD, you'll notice that this stock has been uptrending strong over the last three months, with shares soaring higher from its low of $2.03 to its recent high of $5.27 a share. During that uptrend, shares of TXMD have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of TXMD within range of triggering a big breakout trade.

  Traders should now look for long-biased trades in TXMD if it manages to break out above some near-term overhead resistance levels at $4.93 a share to its 52-week high at $5.27 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average volume of 450,661 shares. If that breakout triggers soon, then TXMD will set up to enter new 52-week high territory, which is bullish technical price action. Some possible upside targets off that breakout are $6 to $7 a share.

  Traders can look to buy TXMD off weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at 4.30 a share, or near its 50-day moving average of $4.15 a share. One can also buy TXMD off strength once it starts to clear those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

• [By John Udovich]

  Yesterday, mid cap women�� health stock Hologic, Inc (NASDAQ: HOLX) fell more than 10% after disappointing Wall Street on earnings,�meaning it might be time to take a look at it and�small cap women�� health stocks�The Female Health Company (NASDAQ: FHCO) and TherapeuticsMD Inc (NYSEMKT: TXMD) because after all, women account for half the population and these three small caps are all focused on the women�� health:

Best Managed Healthcare Companies To Watch For 2015: Rockwell Medical Technologies Inc.(RMTI)

Rockwell Medical Technologies, Inc. manufactures, sells, and distributes hemodialysis concentrate solutions and dialysis kits primarily in the United States, Latin America, Asia, and Europe. The company?s hemodialysis product duplicates kidney function in patients with failing kidneys, known as end stage renal disease, an advanced stage of chronic kidney disease; and dialysis solutions are used to maintain life, remove toxins, and replace nutrients in the dialysis patient?s bloodstream. Its products include Renal Pure and CitraPure liquid acid concentrate, Dri-Sate dry acid concentrate and mixing systems, RenalPure powder bicarbonate concentrate, and SteriLyte liquid bicarbonate concentrates; and various ancillary products comprising blood tubing, fistula needles, specialized custom kits, dressings, cleaning agents, filtration salts, and other supplies. The company also has a license to manufacture and sell soluble ferric pyrophosphate (SFP), a Phase III clinical trial p roduct to improve the treatment of dialysis patients with iron deficiency. Rockwell Medical Technologies sells its products to domestic hemodialysis providers through direct sales people and independent sales representation companies, as well as through independent sales agents and distributors internationally. The company was founded in 1995 and is based in Wixom, Michigan.

Advisors' Opinion:

• [By Jake L'Ecuyer]

  Rockwell Medical (NASDAQ: RMTI) was also down, falling 19.90 percent to $10.80 after Brean Capital initiated the company at a Sell rating and a $4 price target.

Best Managed Healthcare Companies To Watch For 2015: Shiloh Industries Inc.(SHLO)

Shiloh Industries, Inc., together with its subsidiaries, manufactures and sells first operation blanks, engineered welded blanks, stampings, and modular assemblies for the automotive, heavy truck, and other industrial markets. The company offers blanks for use in structural and exterior steel components, such as support brackets, frame sides, fenders, hoods and doors; and stampings primarily for use as components in mufflers, seat frames, structural rails, window lifts, heat shields, vehicle brakes, and other structural body components. It builds modular assemblies, including components in the structural and powertrain systems of vehicles. The company also designs, engineers, and sells precision tools and dies, and welding and assembly equipment to original equipment manufacturers, automotive suppliers, and other industrial customers. In addition, it offers a range of intermediate steel processing services, such as oiling, leveling, cutting-to-length, multi-blanking, slitt ing, edge trimming of hot and cold-rolled steel coils, and inventory control services for automotive and steel industry customers. The company supplies its products to automotive manufacturers and automotive suppliers, as well as to manufacturers in the lawn and garden, and heavy duty truck and trailer industries. Shiloh Industries was founded in 1950 and is based in Valley City, Ohio. Shiloh Industries, Inc. is a subsidiary of MTD Holdings Inc.

Advisors' Opinion:

• [By Monica Gerson]

  Shiloh Industries (NASDAQ: SHLO) is projected to report its Q3 earnings.

  Quiksilver (NYSE: ZQK) is expected to post its Q3 earnings at $0.03 per share on revenue of $440.64 million.

Best Managed Healthcare Companies To Watch For 2015: Bunge Limited(BG)

Bunge Limited, through its subsidiaries, engages in the agriculture and food businesses worldwide. Its Agribusiness segment is involved in purchasing, storing, transporting, processing, and selling agricultural commodities and commodity products, such as oilseeds and grains, primarily comprising soybeans, rapeseed or canola, sunflower seed, wheat, and corn. This segment serves animal feed manufacturers, wheat and corn millers, third party edible oil processing companies, and other oilseed processors, as well as livestock, poultry, and aquaculture producers. The company?s Sugar and Bioenergy segment produces and sells sugar and ethanol; generates electricity from burning sugarcane bagasse; and trades and merchandises sugar. As of December 31, 2011, this segment had a total installed capacity of approximately 144 megawatts; and sugarcane plantations of approximately 183,000 hectares under cultivation. Its Edible Oil Products segment offers packaged vegetable, including pack aged and bulk oils, shortenings, margarines, mayonnaise, and other products to baked goods companies, snack food producers, restaurant chains, foodservice distributors, and other food manufacturers. The company?s Milling Products segment produces and sells various wheat flours and bakery mixes; corn-based products; corn milling products primarily comprising dry milled corn meals, flours, and grits, as well as soy-fortified corn meal and corn-soy blend; and packaged milled rice. This segment serves industrial, bakery, and foodservice companies; and companies in food processing sector. Its Fertilizer segment produces, blends, and distributes nitrogen, phosphate, and potash formulations used for the cultivation of soybeans, corn, sugarcane, cotton, wheat, and coffee. This segment also produces single super phosphate; and ammonia, urea, and liquid fertilizers for the agriculture industry. Bunge Limited was founded in 1818 and is headquartered in White Plains, New York.

Advisors' Opinion:

• [By Maxx Chatsko]

  That missing production is a slight blow in the short term. SRN was only going to contribute 2,500 MT of oils by the end of 2014 and, if expanded further, only 25,000 MT. By contrast, Solazyme will capture much larger production volumes with its partner Archer Daniels Midland (NYSE: ADM  ) and in its joint venture with Bunge (NYSE: BG  )

• [By Rich Duprey]

  Now both Bunge (NYSE: BG  ) and Cargill, the biggest U.S. grain exporter,�have said they will refuse to accept Syngenta's latest crop of GM corn for export because it will be rejected by China. Although the seeds containing the�Agrisure Duracade trait were approved for planting by the FDA last year, making this year's crop the first containing them, it hasn't been approved by Europe or China. In December, China refused�acceptance of 665,000 metric tons of corn and byproducts because it tested positive for the presence of MIR162, or Agrisure Viptera,�a genetically modified�insecticide not approved for import.

• [By Ben Levisohn]

  Korn and Teller downgraded Mosaic to Equal Weight from Overweight, but expect CF Industries (CF), Agrium and Bunge (BG) to do well in 2014, despite no obvious catalysts.

• [By Rich Duprey]

  Rivals such as Bunge (NYSE: BG  ) already have a larger presence already in the region, with Bunge generating 18% of its $62.9 billion in revenues from Asia. It derives less than a third from the U.S., thus spreading out its geographic risk better.